NeuroBo Pharmaceuticals Statistics

Total Valuation

NRBO has a market cap or net worth of $20.42 million. The enterprise value is -$1.11 million.

Market Cap	20.42M
Enterprise Value	-1.11M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

NRBO has 8.62 million shares outstanding. The number of shares has increased by 60.13% in one year.

Current Share Class	8.62M
Shares Outstanding	8.62M
Shares Change (YoY)	+60.13%
Shares Change (QoQ)	+88.14%
Owned by Insiders (%)	0.85%
Owned by Institutions (%)	3.16%
Float	2.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.58
P/TBV Ratio	1.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.01.

Current Ratio	2.41
Quick Ratio	2.38
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -160.76% and return on invested capital (ROIC) is -103.55%.

Return on Equity (ROE)	-160.76%
Return on Assets (ROA)	-74.35%
Return on Capital (ROIC)	-103.55%
Revenue Per Employee	n/a
Profits Per Employee	-$3.47M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.10% in the last 52 weeks. The beta is -0.28, so NRBO's price volatility has been lower than the market average.

Beta (5Y)	-0.28
52-Week Price Change	-31.10%
50-Day Moving Average	2.80
200-Day Moving Average	3.84
Relative Strength Index (RSI)	40.38
Average Volume (20 Days)	36,684

Short Selling Information

The latest short interest is 19,204, so 0.22% of the outstanding shares have been sold short.

Short Interest	19,204
Short Previous Month	24,056
Short % of Shares Out	0.22%
Short % of Float	0.87%
Short Ratio (days to cover)	0.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-28.89M
Pretax Income	-16.58M
Net Income	-27.73M
EBITDA	-28.87M
EBIT	-28.89M
Earnings Per Share (EPS)	-$4.29

Full Income Statement

Balance Sheet

The company has $21.68 million in cash and $154,000 in debt, giving a net cash position of $21.53 million or $2.50 per share.

Cash & Cash Equivalents	21.68M
Total Debt	154,000
Net Cash	21.53M
Net Cash Per Share	$2.50
Equity (Book Value)	12.95M
Book Value Per Share	1.50
Working Capital	12.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$22.68 million and capital expenditures -$17,000, giving a free cash flow of -$22.69 million.

Operating Cash Flow	-22.68M
Capital Expenditures	-17,000
Free Cash Flow	-22.69M
FCF Per Share	-$2.63

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-60.13%
Shareholder Yield	-60.13%
Earnings Yield	-135.81%
FCF Yield	-111.13%

Analyst Forecast

The average price target for NRBO is $10.00, which is 321.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	321.94%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 21, 2023. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Dec 21, 2023
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1